XTAE
GEFR
Market cap66mUSD
Jul 10, Last price
82.60ILS
1D
1.10%
1Q
-2.36%
IPO
-91.21%
Name
Geffen Residence & Renewal Ltd
Chart & Performance
P/E
—
P/S
296.03
EPS
—
Div Yield, %
—
Shrs. gr., 5y
30.52%
Rev. gr., 5y
-47.94%
Revenues
685k
+422.90%
Net income
-5m
L+0.97%
CFO
-17m
L+5.32%
Dividend
Sep 30, 20156.6337 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||